1. Stereotactic Body Radiotherapy for Oligometastatic Prostate Cancer Detected via Prostate-specific Membrane Antigen Positron Emission Tomography 
Andrew Kneebone, George Hruby, Hannah Ainsworth, Keelan Byrne, Chris Brown, Linxin Guo, Alexander Guminski, Thomas Eade 
European Urology Oncology 
Volume 1, Issue 6, Pages (December 2018)
DOI: /j.euo
Copyright © 2018 European Association of Urology Terms and Conditions

2. Fig. 1 Example of the stereotactic body radiotherapy technique.
European Urology Oncology 2018 1, DOI: ( /j.euo )
Copyright © 2018 European Association of Urology Terms and Conditions

3. Fig. 2
Waterfall plot of the best prostate-specific antigen (PSA) response after stereotactic body radiotherapy (SBRT) compared to baseline by biochemical failure. The change was computed relative to the reading before SBRT and expressed as a percentage. Five bars (with value noted) have been truncated.
European Urology Oncology 2018 1, DOI: ( /j.euo )
Copyright © 2018 European Association of Urology Terms and Conditions

4. Fig. 3
Biochemical failure for the entire cohort. PFS=progression-free survival.
European Urology Oncology 2018 1, DOI: ( /j.euo )
Copyright © 2018 European Association of Urology Terms and Conditions